- Home
- BRLT vs PYPD Comparison
BRLT vs PYPD Comparison
Compare BRLT & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRLT
- PYPD
- Stock Information
- Founded
- BRLT 2005
- PYPD 2008
- Country
- BRLT United States
- PYPD Israel
- Employees
- BRLT N/A
- PYPD N/A
- Industry
- BRLT Consumer Specialties
- PYPD Medical/Dental Instruments
- Sector
- BRLT Consumer Discretionary
- PYPD Health Care
- Exchange
- BRLT Nasdaq
- PYPD Nasdaq
- Market Cap
- BRLT 22.7M
- PYPD 24.2M
- IPO Year
- BRLT 2021
- PYPD 2020
- Fundamental
- Price
- BRLT $1.71
- PYPD $3.56
- Analyst Decision
- BRLT Buy
- PYPD Strong Buy
- Analyst Count
- BRLT 4
- PYPD 2
- Target Price
- BRLT $3.00
- PYPD $12.00
- AVG Volume (30 Days)
- BRLT 110.0K
- PYPD 8.1K
- Earning Date
- BRLT 11-07-2024
- PYPD 11-13-2024
- Dividend Yield
- BRLT N/A
- PYPD N/A
- EPS Growth
- BRLT N/A
- PYPD N/A
- EPS
- BRLT 0.03
- PYPD N/A
- Revenue
- BRLT $426,982,000.00
- PYPD N/A
- Revenue This Year
- BRLT N/A
- PYPD N/A
- Revenue Next Year
- BRLT $3.14
- PYPD N/A
- P/E Ratio
- BRLT $62.24
- PYPD N/A
- Revenue Growth
- BRLT N/A
- PYPD N/A
- 52 Week Low
- BRLT $1.52
- PYPD $2.95
- 52 Week High
- BRLT $3.81
- PYPD $9.20
- Technical
- Relative Strength Index (RSI)
- BRLT 47.30
- PYPD 54.93
- Support Level
- BRLT $1.66
- PYPD $3.30
- Resistance Level
- BRLT $1.88
- PYPD $3.59
- Average True Range (ATR)
- BRLT 0.14
- PYPD 0.21
- MACD
- BRLT 0.02
- PYPD 0.02
- Stochastic Oscillator
- BRLT 47.22
- PYPD 68.27
About BRLT Brilliant Earth Group Inc.
Brilliant Earth Group Inc designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. Its sales consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.